Home » Authors » Kim Coghill

Articles by Kim Coghill

AEterna Gains Positive Results In Phase III Trial Of Impavido

July 30, 2003

AEterna Gains Positive Results In Phase III Trial Of Impavido

July 30, 2003

ISTA Gets Approvable Letter On Product To Treat Glaucoma

July 29, 2003

ISTA Gets Approvable Letter On Product To Treat Glaucoma

July 29, 2003

House Passes Bill That Would Allow Reimportation Of Drugs

July 28, 2003

House Passes Bill That Would Allow Reimportation Of Drugs

July 28, 2003

Senate Agrees To Requirement On Studies For Pediatric Drugs

July 25, 2003

Senate Agrees To Requirement On Studies For Pediatric Drugs

July 25, 2003

Micrologix Takes Hit On Failed Phase III Blood Infection Trial

July 24, 2003

Micrologix Takes Hit On Failed Phase III Blood Infection Trial

July 24, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...